11th Nov 2008 10:53
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
Deltex Medical Group Plc
2. Reason for the notification (please state Yes/No): ( )
An acquisition or disposal of voting rights: ( X )
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify): ( )
3. Full name of person(s) subject to the notification obligation (iii):
Barclays PLC
4. Full name of shareholder(s) (if different from 3.) (iv):
Barclays Stockbrokers Ltd
Gerrard Investment Management Ltd
5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):
7 November 2008
6. Date on which issuer notified:
10 November 2008
7. Threshold(s) that is/are crossed or reached:
Below notifiable % to 5%
8. Notified details:
A: Voting rights attached to shares
|
Class/type of shares if possible using the ISIN CODE |
Situation previous to the Triggering transaction (vi) |
|
|
|
Number of shares |
Number of voting Rights (viii) |
|
GB0059337583 |
35,000 |
35,000 |
Resulting situation after the triggering transaction (vii)
|
Class/type of shares if possible using the ISIN CODE |
Number of shares |
Number of voting rights (ix) |
% of voting rights |
||
|
|
Direct |
Direct (x) |
Indirect (xi) |
Direct |
Indirect |
|
GB0059337583 |
5,014,663 |
0 |
5,014,663 |
0.00 |
5.00 |
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
|
Type of financial instrument |
Expiration Date (xiii) |
Exercise/Conversion Period/ Date (xiv) |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
Total (A+B)
|
Number of voting rights |
% of voting rights |
|
5,014,663 |
5.00 |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):
Barclays Stockbrokers Ltd
Gerrard Investment Management Ltd
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
14. Contact name:
Geoff Smith
15. Contact telephone number:
020 7116 2913
Related Shares:
Deltex MedicalBarclays